Continuous combined hormone replacement therapy and risk of endometrial cancer
- 1 December 2000
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 183 (6) , 1456-1461
- https://doi.org/10.1067/mob.2000.108081
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal WomenJAMA, 1996
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Estrogen Replacement Therapy and Fractures in Older WomenAnnals of Internal Medicine, 1995
- Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens aloneAmerican Journal of Obstetrics and Gynecology, 1994
- Estrogens, Progesterone, and Endometrial CancerEpidemiology, 1993
- Progestagen supplementation of exogenous oestrogens and risk of endometrial cancerThe Lancet, 1991
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980